✦ LIBER ✦

Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study

✍ Scribed by Mattson, K; Abratt, R; Ten, G.Velde; Krofta, K; Tonelli, D; Avril, I

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early results of an international phase

✍ Mattson, K; Ten Velde, G; Krofta, K; Cour-Chabernaud, V; Abratt, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Analysis of prognostic factors for surge

✍ Xuefeng Zhou; Jianjun Wang; Jiashun Wang; Yongcheng Pan; Jingsong Li; Wendong Wa 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 Chinese ⚖ 362 KB

Docetaxel plus cisplatin as neoadjuvant

✍ Dediu, M; Horvat, T; Tarlea, A; Nicodin, A; Movanu, M; Radult, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Adjuvant chemotherapy for completely res

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Phase I study to determine MTD of doceta

✍ You-quan Li; An-hui Shi; Fu-hai Li; Rong Yu; Guang-ying Zhu 📂 Article 📅 2011 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 231 KB

Preoperative chemoradiotherapy for stage

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 133 KB